Christian O. Henry

CIK: 0001263805

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)15 (57.7%)

Position reduction

Option Exercises (M)5 (19.2%)

Derivative conversions

Awards (A)6 (23.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

WVE

Wave Life Sciences, Inc.

Director

DNA

Ginkgo Bioworks Holdings, Inc.

Director

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

WVE
Wave Life Sciences, Inc.
Oct 5, 2026
Award(A)
Direct
10.7K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Sep 15, 2026
Sale(S)
Direct
5K shares at avg. $7.08$35K
DNA
Ginkgo Bioworks Holdings, Inc.
Jun 11, 2026
Award(A)
Restricted Stock Units
Direct
25K shares-
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Mar 3, 2026
Sale(S)
Direct
12.5K shares at avg. $1.51$19K
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Feb 27, 2026
Award(A)
Direct
920.8K shares-
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Feb 18, 2026
Sale(S)
Direct
140.9K shares at avg. $1.63$229K
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Feb 17, 2026
Sale(S)
Direct
331.8K shares at avg. $1.58$523K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
6.4K shares at avg. $12.75$82K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
42K shares at avg. $5.97$251K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
42K shares at avg. $12.75$536K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
15K shares at avg. $3.50$53K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
15K shares at avg. $14.07$211K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
30K shares at avg. $4.58$138K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
30K shares at avg. $18.02$541K
DNA
Ginkgo Bioworks Holdings, Inc.
Sep 9, 2025
Sale(S)
Direct
10K shares at avg. $11.06$111K
DNA
Ginkgo Bioworks Holdings, Inc.
Sep 8, 2025
Sale(S)
Direct
10K shares at avg. $10.92$109K
WVE
Wave Life Sciences Ltd.
Aug 13, 2025
Sale(S)
Direct
9.7K shares at avg. $8.81$85K
WVE
Wave Life Sciences Ltd.
Aug 11, 2025
Award(A)
Direct
12.7K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Jun 12, 2025
Award(A)
Stock Option
Direct
34.4K shares-
DNA
Ginkgo Bioworks Holdings, Inc.
Jun 11, 2025
Exercise(M)
Direct
10.8K shares-
WVE
Wave Life Sciences Ltd.
Mar 20, 2025
Exercise(M)
Direct
10.5K shares at avg. $9.13$96K
WVE
Wave Life Sciences Ltd.
Mar 20, 2025
Sale(S)
Direct
10.5K shares at avg. $9.77$103K
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Mar 19, 2025
Award(A)
Direct
920.8K shares-
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Mar 3, 2025
Sale(S)
Direct
12.5K shares at avg. $1.41$18K
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Feb 18, 2025
Sale(S)
Direct
259.9K shares at avg. $1.88$488K

		Type	Shares	Price		Ownership
Oct 5, 2026	WVE Wave Life Sciences, Inc.	Award(A)	10,700	-	$0	Direct
Sep 15, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	5,000	$7.08	$35,405	Direct
Jun 11, 2026	DNA Ginkgo Bioworks Holdings, Inc.	Award(A) Restricted Stock Units	25,000	-	-	Direct
Mar 3, 2026	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Sale(S)	12,497	$1.51	$18,920	Direct
Feb 27, 2026	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Award(A)	920,810	-	$0	Direct
Feb 18, 2026	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Sale(S)	140,874	$1.63	$229,484	Direct
Feb 17, 2026	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Sale(S)	331,793	$1.58	$522,906	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	6,445	$12.75	$82,174	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	42,000	$5.97	$250,740	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	42,000	$12.75	$535,500	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	15,000	$3.50	$52,500	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	15,000	$14.07	$211,050	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	30,000	$4.58	$137,550	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	30,000	$18.02	$540,600	Direct
Sep 9, 2025	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	10,000	$11.06	$110,600	Direct
Sep 8, 2025	DNA Ginkgo Bioworks Holdings, Inc.	Sale(S)	10,000	$10.92	$109,200	Direct
Aug 13, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	9,670	$8.81	$85,193	Direct
Aug 11, 2025	WVE Wave Life Sciences Ltd.	Award(A)	12,700	-	-	Direct
Jun 12, 2025	DNA Ginkgo Bioworks Holdings, Inc.	Award(A) Stock Option	34,375	-	-	Direct
Jun 11, 2025	DNA Ginkgo Bioworks Holdings, Inc.	Exercise(M)	10,822	-	-	Direct
Mar 20, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	10,500	$9.13	$95,865	Direct
Mar 20, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	10,500	$9.77	$102,575	Direct
Mar 19, 2025	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Award(A)	920,810	-	-	Direct
Mar 3, 2025	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Sale(S)	12,497	$1.41	$17,583	Direct
Feb 18, 2025	PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	Sale(S)	259,909	$1.88	$488,109	Direct

1-25 of 26 transactions

About HENRY CHRISTIAN O

HENRY CHRISTIAN O (SEC CIK 0001263805) files insider reports with the SEC as Director of Wave Life Sciences, Inc. (WVE), Director of Ginkgo Bioworks Holdings, Inc. (DNA) and Officer of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).

Signal8 holds 15 ownership filings by HENRY CHRISTIAN O, all Form 4s, filed between Sep 17, 2024 and Oct 7, 2026. Those filings report 26 transactions, from Sep 16, 2024 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HENRY CHRISTIAN O's filings is in CAMBRIDGE, MA.

Recent filings by HENRY CHRISTIAN O

Oct 5, 2026: Grant or award of WVE shares (Form 4, code A).
Sep 15, 2026: Open-market sale of DNA shares (Form 4, code S).
Jun 11, 2026: Grant or award of DNA derivative securities (Form 4, code A).
Mar 3, 2026: Open-market sale of PACB shares (Form 4, code S).
Feb 27, 2026: Grant or award of PACB shares (Form 4, code A).

Other insiders filing for Wave Life Sciences, Inc. (WVE)

RA CAPITAL MANAGEMENT, L.P., Director
Verdine Gregory L., Director
Tan Aik Na, Director
TAKANASHI KEN, Director
CORRIGAN MARK, Director
Rawcliffe Adrian, Director

How to read Form 4 transaction codes